The FDA announced on Dec. 21, 2018, that Lupin Somerset is recalling Nitrofurantoin Oral Suspension due to subpotent drug risks. The agency said the recall expands a June 2018 action involving lots with below-specification assay results.
How to tell if you have it
- Brand: Lupin Somerset
- Product: Nitrofurantoin Oral Suspension, USP, 25mg/5mL, 230 mL bottle
- NDC: 43386-450-11
- Manufactured by: Novel Laboratories, Inc.
- Lots: S700038, S700044, S700059, S700065, S700410, S700427, S700617, S700619, S700813, S700815, S700869, S700871, S700873, S700875, S701073
- Distribution: Nationwide in the USA and Puerto Rico
The hazard
The FDA said the product is subpotent due to below-specification assay results. This recall expands a June 2018 recall of lots S700065 and S700619.
Context
GovInfoNow's records show Lupin Somerset has 8 other recalls on record since May 24, 2018. Other recent recalls of similar products include Lupin Somerset Morphine Sulfate Tablets Recall (April 10, 2019), Lupin Recalls Gavilyte-N Packets Due to Labeling Error (March 19, 2019), and Lupin Recalls Fluocinolone Acetonide Topical Solution Due to Impurities (Jan. 15, 2019).